Quality of medication therapy in patients after stroke depending on presence/absence of diabetes: data from the outpatient stage of REGION-M registry
Open Access
- 4 July 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (5), 2856
- https://doi.org/10.15829/1728-8800-2021-2856
Abstract
Aim. To assess the quality of medication treatment in the polyclinic within 2 years after discharge, depending on presence/absence of diarecommended for patients with stroke before its development and betes.Material and methods. The study included 684 patients assigned to the City Polyclinic № 64 (Moscow), discharged from F.I. Inozemtsev City Clinical Hospital (Moscow) for a period from January 1, 2012 to April 30, 2017 with a diagnosis of stroke/transient ischemic attack, of which 122 were diagnosed with diabetes.Results. Before stroke, therapy was recommended for 67,3% of patients with diabetes and 54,7% without diabetes (pConclusion. The therapy of patients with previous stroke, both with and without diabetes, recommended in the polyclinic, is characterized by an insufficient prescription rate of main drug classes necessary for secondary cardiovascular prevention at all follow-up stages.Keywords
This publication has 13 references indexed in Scilit:
- Long-Term Prognosis after Transient Ischemic Attack and StrokePublished by Cambridge University Press (CUP) ,2018
- Reduction in stroke death rates through a package of measures to improve medical care for patients with vascular diseases in the Russian FederationProfilakticheskaya meditsina, 2018
- Correction to: Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart AssociationJournal of the American College of Cardiology, 2017
- SECONDARY PREVENTION OF ISCHEMIC STROKE: INTERNATIONAL RECOMMENDATIONS AND CLINICAL PRACTICEThe Neurological Journal, 2015
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke, 2014
- TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2)Rational Pharmacotherapy in Cardiology, 2013
- LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATIONRational Pharmacotherapy in Cardiology, 2013
- RISK FACTORS AND PECULIARITIES OF CEREBRAL VESSELS ALTERATION IN PATIENTS WITH TYPE 2 DIABETES IN ASSOCIATION WITH CEREBROVASCULAR DISEASEI.P. Pavlov Russian Medical Biological Herald, 2012
- Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008Cerebrovascular Diseases, 2008
- American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guidelineAmerican Journal of Ophthalmology, 2006